Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
Abstract Peripheral decarboxylase inhibitors (PDIs) prevent conversion of levodopa to dopamine in the blood by the enzyme aromatic L-amino acid decarboxylase (AADC). Alterations in enzyme activity may contribute to the required higher dosages of levodopa observed in many patients with Parkinson’s di...
Guardado en:
Autores principales: | Anouke van Rumund, Lukas Pavelka, Rianne A. J. Esselink, Ben P. M. Geurtz, Ron A. Wevers, Brit Mollenhauer, Rejko Krüger, Bastiaan R. Bloem, Marcel M. Verbeek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3eebeb9442ff4f699abd025afeca8d9b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
por: Toni S. Pearson, et al.
Publicado: (2021) -
Visualizing the enzyme mechanism of mevalonate diphosphate decarboxylase
por: Chun-Liang Chen, et al.
Publicado: (2020) -
Pyrazinamide triggers degradation of its target aspartate decarboxylase
por: Pooja Gopal, et al.
Publicado: (2020) -
In silico/computational analysis of mevalonate pyrophosphate decarboxylase gene families in Campanulids
por: Cui Minghui, et al.
Publicado: (2021) -
Aconitate decarboxylase 1 participates in the control of pulmonary Brucella infection in mice.
por: Aurore Demars, et al.
Publicado: (2021)